ABI-H2158 Reference Formulation: Clinical Trials

1 trial of ABI-H2158 Reference Formulation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow ABI-H2158 Reference Formulation: new trials by email Literature Review of ABI-H2158 Reference Formulation trials Research Report on ABI-H2158 Reference Formulation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults
ABI-H2158 Reference Formulation, ABI-H2158 Test Formulation - Chronic Hepatitis B
Phase 1CompletedAssembly Biosciences152019-09-062019-11-29

Conditions studied

Hepatitis B, Chronic (1)

Sponsors

Assembly Biosciences (1)

Countries

United States (1)

Top investigators

Marc Evanchik (1)